|
Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment
Wendy Lorizio, Hope Rugo, Mary S Beattie, Simone Tchu, Teri Melese, Michelle Melisko, Alan HB Wu, H Jeffrey Lawrence, Michele Nikoloff, Elad Ziv Genome Medicine 2011, 3:64 (4 October 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
The choice of medication for breast cancer patients was changed after CYP2D6 genotyping, demonstrating for the first time that pharmacogenetics can shape clinical treatment decisions.
|